泰福资本

Empower Innovative Biotech

TF Capital aims to be the first and most significant institutional investor for early-stage innovative biotechs with whole value-chain service. In the rapidly growing global biopharmaceutical industry, TF Capital is committed to identifying and nurturing the most promising innovative and cutting-edge companies. With the robostic and diverse resouces from listed companies, renowed clinical resouces, reputable funds, TF capital is dedicated in impactful investment in biotech, medical devices, and CRO industry.
$1B
AUM
3
Locations
100+
Portfolios
20
IPO
Comprehensive whole value-chain support and extensive network
TF capital has established strong relationships with leading biotech parks like BioBAY, Lingang, and Nanjing Biotech and Pharmaceutical Valley for streamlined company registration and strategic partnerships.
The firm provides crucial pre-clinical and clinical trial resources through collaborations with organizations such as AcmeTech, Pharmalegacy, Tigermed, and Sunflower. Additionally, TF Capital ensures strong operational support via in-house headhunting for CXO-level talent and experienced legal, finance, and administrative teams.
Its deep industry connections include investments from and collaborations with listed companies (e.g., Walvax, Sanyou) and reputable funds, fostering a robust ecosystem for co-investment and portfolio growth.
Global Expansion
TF Capital's strategic global expansion into key biopharma hubs—Boston, Ireland, and Shanghai—to foster innovation, leverage local ecosystems, and strengthen cross-regional collaboration in the biopharmaceutical industry.

Empower Innovative Biotech

$1B

AUM

3

Locations

100+

Portfolios

20

IPO

Comprehensive whole value-chain support and extensive network

Global Expansion

TF Capital's strategic global expansion into key biopharma hubs—Boston, Ireland, and Shanghai—to foster innovation, leverage local ecosystems, and strengthen cross-regional collaboration in the biopharmaceutical industry.